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Development/Plasticity/Repair

Astrocyte-Derived Thrombospondins Mediate the
Development of Hippocampal Presynaptic Plasticity In Vitro
Devon C. Crawford,1,2 Xiaoping Jiang,2 Amanda Taylor,2 and Steven Mennerick2,3
Graduate Program in Neuroscience, and Departments of 2Psychiatry and 3Anatomy and Neurobiology, Washington University School of Medicine, St.
Louis, Missouri 63110

1

Astrocytes contribute to many neuronal functions, including synaptogenesis, but their role in the development of synaptic plasticity
remains unclear. Presynaptic muting of hippocampal glutamatergic terminals defends against excitotoxicity. Here we studied the role of
astrocytes in the development of presynaptic muting at glutamatergic synapses in rat hippocampal neurons. We found that astrocytes
were critical for the development of depolarization-dependent and Gi/o-dependent presynaptic muting. The ability of cAMP analogues to
modulate presynaptic function was also impaired by astrocyte deficiency. Although astrocyte deprivation resulted in postsynaptic
glutamate receptor deficits, this effect appeared independent of astrocytes’ role in presynaptic muting. Muting was restored with chronic,
but not acute, treatment with astrocyte-conditioned medium, indicating that a soluble factor is permissive for muting. Astrocyte-derived
thrombospondins (TSPs) are likely responsible because TSP1 mimicked the effect of conditioned medium, and gabapentin, a highaffinity antagonist of TSP binding to the ␣2␦-1 calcium channel subunit, mimicked astrocyte deprivation. We found evidence that protein
kinase A activity is abnormal in astrocyte-deprived neurons but restored by TSP1, so protein kinase A dysfunction may provide a
mechanism by which muting is disrupted during astrocyte deficiency. In summary our results suggest an important role for astrocytederived TSPs, acting through ␣2␦-1, in maturation of a potentially important form of presynaptic plasticity.

Introduction
Correct development and plasticity of glutamate synapses is critical to brain function. Imbalances between excitatory and inhibitory neurotransmitter actions are postulated to underlie brain
disturbances as diverse as schizophrenia (Lewis and Moghaddam, 2006), developmental disability (Rubenstein and Merzenich, 2003; Wetmore and Garner, 2010), and epilepsy
(McCormick and Contreras, 2001). Diverse cues regulate synaptic development; neuron-to-neuron signaling is clearly important for synaptogenesis (Craig et al., 2006), but astrocytic factors
are also important (Eroglu and Barres, 2010; Pfrieger, 2010). Still
unclear is the breadth of astrocyte involvement in synapse development and the signaling systems affected. Astrocytic cues likely
guide postsynaptic function, presynaptic function, synaptic plasticity, and combinations of these elements.
Our group and others have studied a form of adaptive presynaptic plasticity termed muting whereby the number of terminals
releasing transmitter is reduced. Mute presynaptic terminals are
found in a variety of preparations (Tong et al., 1996; Bolshakov et
al., 1997; Kannenberg et al., 1999; Ma et al., 1999; Kim et al., 2003;
Losonczy et al., 2004; Moulder et al., 2004; Cousin and Evans,
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2011; Crawford and Mennerick, 2012). Reversible muting of hippocampal glutamatergic synapses occurs in cultured autaptic
neurons, conventional mass cultures, and acute hippocampal
slices (Moulder et al., 2004; Crawford et al., 2011). Muting is
induced by electrical stimulation, depolarization challenges, prolonged Gi/o G-protein activation, and hypoxia (Moulder et al.,
2004, 2006, 2008; Crawford et al., 2011; Hogins et al., 2011; Crawford and Mennerick, 2012). Muting may play a role in defending
against excitotoxic glutamate release (Hogins et al., 2011), but it
is also engaged by physiological changes in activity (Moulder et
al., 2006). Despite the wide variety of preparations and conditions under which muting occurs (Crawford and Mennerick,
2012), factors controlling development of muting have not been
explored.
Muting occurs in single-neuron networks in culture, but because
these neurons contact astrocytes it is unclear whether muting is cell
autonomous or whether astrocyte signals modulate or induce muting. Here we explored muting mechanisms in a reduced environment where astrocyte numbers could be controlled. We found that
global, permissive astrocytic signaling rather than local, instructive
astrocytic signaling is important for the development of muting.
Astrocyte deprivation prevented muting in response to both depolarization and G-protein-coupled receptor stimulation. Chronic,
but not acute, treatment with astrocyte-conditioned medium rescued muting. Thrombospondins (TSPs), astrocyte-derived glycoproteins previously implicated in glutamate synapse development
(Asch et al., 1986; Christopherson et al., 2005; Eroglu et al., 2009; Xu
et al., 2010), also rescued muting. Gabapentin, an antagonist of the
TSP receptor ␣2␦-1 (Gee et al., 1996; Eroglu et al., 2009), mimicked
the effects of astrocyte deprivation by preventing muting compe-
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treatment corrected these abnormalities.
Our results suggest that astrocyte-derived
TSPs are important developmental modulators of presynaptic plasticity.

Materials and Methods
Primary hippocampal cultures. All experiments
were performed in accordance with National
Institutes of Health guidelines and were approved by the Washington University Animal
Studies Committee. For microcultures, culture
dishes (35 mm) were first covered with a thin
layer of 0.15% agarose and then stamped with
150- to 200-m-diameter microdots of 0.5
mg/ml collagen using a polydimethylsiloxane
microstamp as previously described (Moulder
et al., 2007). Cortical astrocytes from postnatal
d 4 male and female rat pups were seeded on
these islands in Eagle’s medium (Life Technologies) supplemented with 5% heat-inactivated
horse serum, 5% fetal bovine serum, 17 mM
D-glucose, 400 M glutamine, 50 U/ml penicillin, and 50 g/ml streptomycin. Glial preplates
were maintained in a humidified and atmospherically controlled incubator (5% CO2/
95% air at 37°C) before neuronal plating.
Astrocyte-poor cultures were prepared 7–10 d
after glial plating by fixation with 4% paraformaldehyde/0.2% glutaraldehyde in PBS at
room temperature (RT) for 5 min before at
least 3 washes in PBS. Alternatively, 70% ethanol at ⫺20°C was applied for 30 min before
PBS rinses. Although most experiments used
aldehyde fixation, both astrocyte fixation protocols produced the finding shown in Figure
1 B. For mass cultures used in Figure 5 (see below), a confluent layer of polylysine/laminin
was applied to the culture dish before neuronal
plating.
Hippocampal neurons were dispersed on
fixed or live astrocyte beds for microcultures
while astrocytes and neurons were coplated for
mass cultures as previously described (Mennerick et al., 1995). Briefly, male and female
postnatal d 0 –3 Sprague Dawley rat hippocampi were dissected, incubated with 1
mg/ml papain, and mechanically dissociated.
To encourage the formation of autaptic (solitary) neurons in microcultures, cells were
Figure 1. Astrocyte deprivation impairs presynaptic muting but not G-protein activation. A, Phase-contrast and fluorescence
plated at low density (⬃100 cells/mm 2). For
images of autaptic neurons on viable (control) or nonviable (4% paraformaldehyde/0.2% glutaraldehyde-fixed) glial “islands”
mass cultures, cells were plated at high density
acquired 30 min after 5 g/ml calcein-AM treatment. Fewer islands contained live (calcein-positive) astrocytes in fixed cultures
(⬃650 cells/mm 2) to encourage neuron–as⫺11
(control: 98.8 ⫾ 0.9% live islands; fixed: 17.6 ⫾ 2.8% live islands; n ⫽ 6 dishes; p ⫽ 7.9 ⫻ 10 , Student’s unpaired t test).
trocyte cocultures to form. After 3– 4 days in
Scale bar, 40 m. B, Representative autaptic EPSCs from astrocyte-rich or astrocyte-poor microcultures recorded in normal saline
vitro (DIV), 6.7 M cytosine arabinoside was
up to 1 h after 4 h control treatment (30 mM NaCl) or after 4 h depolarization (30 mM KCl). C, Summary of peak EPSC amplitudes from
added to inhibit cell division. One half of the
DIV 10 –14 astrocyte-rich (⫹) or astrocyte-poor (⫺) autaptic neurons after indicated treatment times with 30 mM KCl (black bars),
culture medium was exchanged with Neuro10 nM CCPA (A1 adenosine receptor agonist) plus 50 M baclofen (GABAB receptor agonist) (C⫹B; yellow bars), or 50 M
basal medium (Life Technologies) plus B27
Rp-cAMPS (Rp; cyan bars). EPSCs were normalized to the average EPSCs from control-treated sibling neurons for each recording day
supplement at DIV 4 –5. Conditioned media
(n ⫽ 14 –22 neurons; *p ⬍ 0.05 vs treatment controls, Student’s unpaired t test). D, EPSCs from astrocyte-rich or astrocyte-poor
were from astrocyte cultures or from neuron–
cultures after acute perfusion with recording saline (control) or 20 M baclofen. E, EPSCs from astrocyte-rich or astrocyte-poor
astrocyte cocultures; similar results were obcultures after acute perfusion with recording saline (control) or 10 nM CCPA. The same neurons were used for experiments in D and
tained with both. Non-conditioned medium
E. D, E, Summary data are given in the Results.
was fresh Neurobasal without supplements.
Unless otherwise stated, all experiments were
tence. Gabapentin additionally prevented adaptive network plasticperformed at 10 –14 DIV, and controls were sibling cultures used the
ity. Although the downstream pathways initiated by TSP binding to
same day.
␣2␦-1 remain unclear, astrocyte deprivation led to altered protein
Electrophysiology. Whole-cell voltage-clamp recordings were perkinase A (PKA) activity, as suggested by abnormal responses to
formed on autaptic neurons in micro-island culture unless otherwise
cAMP analogues and hyperphosphorylation of PKA substrates. TSP
stated. Data were collected using pClamp 9 software with a Multiclamp
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700B or Axopatch 200B amplifier and Digidata1322A data acquisition
board (Molecular Devices). Recording saline typically contained the following (in mM): 138 NaCl, 4 KCl, 2 CaCl2, 1 MgCl2, 10 glucose, 10
HEPES, and 25 M D-aminophosphonovalerate (D-APV; Tocris Bioscience) at a pH of 7.25. For current-clamp experiments, recording saline
contained 50 M D-APV and 1 M NBQX. For experiments requiring
NMDA receptor activation, 10 M glycine (Tocris Bioscience) was added
to the saline solution and MgCl2 and D-APV were excluded. Pipette
solution contained the following (in mM): 140 potassium gluconate, 4
NaCl, 0.5 CaCl2, 5 EGTA, and 10 HEPES at a pH of 7.25. For experiments
in which both EPSCs and IPSCs were collected during the same recording
session from autaptic neurons, potassium gluconate was replaced with
140 mM KCl. For network activity experiments that measured spontaneous EPSCs and IPSCs in mass cultures, 130 mM cesium methanesulfonate
replaced potassium gluconate.
Recordings were performed at room temperature. Electrode pipettes
were pulled from borosilicate glass (World Precision Instruments) and
typically had 3– 6 M⍀ resistance, except for current-clamp experiments
in which resistances were 4 –7 M⍀. Access resistance was compensated
85–100% for autaptic EPSC and IPSC recordings, and membrane potential was typically held at ⫺70 mV. For network activity experiments in
mass cultures, neurons were voltage-clamped at ⫺30 mV or ⫺35 mV,
midway between IPSC and EPSC reversal potentials, to measure spontaneous network activity due to excitation and inhibition simultaneously.
Autaptic EPSCs and IPSCs were evoked by a 1.5 ms pulse depolarization
to 0 mV. Paired-pulse responses were obtained by evoking two such
depolarizing pulses 50 ms apart. Signals were sampled at 10 kHz and
low-pass filtered at 4 kHz, except for miniature EPSCs collected at 5
kHz and filtered at 1 kHz and spontaneous EPSCs and IPSCs collected
at 5 kHz and filtered at 2 kHz. Autaptic PSCs were recorded up to 1 h
after switch to recording saline. When solutions were applied acutely
to neurons, a multibarrel perfusion system was used with a common
port placed within 0.5 mm of the neuron; solution exchange times
were ⬃100 ms. Wherever possible, acute effects of drugs were evaluated by interleaving control and drug treatments and averaging 2–5
responses per condition.
Glutamate receptor blockers (50 M D-APV and 1 M NBQX) were
present during all depolarization challenges (30 mM KCl for depolarization or NaCl as a nondepolarized osmotic control) to prevent
toxicity and NMDA receptor-dependent plasticity. Control treatments for all other experiments consisted of vehicle treatment unless
otherwise specified.
Immunostaining and microscopy. FM1-43 dye labeling was performed
as previously described (Moulder et al., 2010). Briefly, microcultures
were treated for 2 min with 10 M fixable FM1-43 (FM1-43FX; Life
Technologies) in recording saline supplemented with 45 mM KCl and 1
M NBQX. Immediately following, the culture dishes were briefly
washed (5 s) in saline supplemented with 500 M Advasep-7 (CyDex
Pharmaceuticals) and 1 M NBQX. Cells rested during 10 min of washes
with saline plus 1 M NBQX and were then fixed for 10 min.
Fixation before immunostaining was 4% paraformaldehyde at RT, 4%
paraformaldehyde/0.2% glutaraldehyde at RT, 4% paraformaldehyde/
0.02% glutaraldehyde at RT, or 100% methanol at ⫺20°C for 10 min. All
culture dishes were washed with PBS at RT followed by 2– 4% normal
goat serum in PBS blocking solution plus 0% (for surface protein levels),
0.1%, or 0.04% Triton X-100. Primary antibodies were vesicular glutamate transporter 1 (vGluT-1; 1:2000; Millipore), GluA2/GluR2 (1:500,
Millipore), microtubule-associated protein 2 (MAP2; 1:2000; Millipore),
phospho-synapsin (1:400; Millipore), synapsin (1:2000; Millipore),
phospho-cAMP response element binding protein (phospho-CREB;
1:400; Millipore), GABA (1:500), and phospho-dynamin 1 (1:100; Santa
Cruz Biotechnology). Primary antibodies were applied for 2–3 h at RT
before PBS wash, 30 – 40 min secondary antibody incubation with Alexa
Fluor conjugates (Life Technologies), and glass coverslipping with Fluoromount G (Southern Biotechnology Associates).
FM1-43FX and immunostaining images were acquired on an inverted
Eclipse TE2000-S microscope with a 60⫻ objective (1.4 numerical aperture) using a C1 scanning confocal laser (488, 543, and/or 633 nm) and
EZ-C1 software (Nikon). Alternating laser lines were used to obtain
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z-stack images while all gain and acquisition settings were held constant
within a given experiment. Two-dimensional projected images were created and analyzed using MetaMorph 7 software (Universal Imaging).
Live cell images were obtained on an Eclipse TE2000-S inverted microscope (Nikon) with a 40⫻ objective (0.6 numerical aperture; Nikon)
and a metal halide lamp. Images were acquired with MetaMorph 7 software and a cooled 12-bit CCD camera (Photometrics).
Data analysis. Data were analyzed and graphed using MetaMorph 7,
Clampfit 9 (Molecular Devices), Mini Analysis 6 (Synaptosoft Inc.), Excel 2007 (Microsoft), and/or SigmaPlot 10 (Systat) software. Unless otherwise stated, data are displayed as mean ⫾ SEM, and Student’s unpaired
t test was used to compare 2 groups while a Bonferroni correction was
applied when experiments contained ⬎2 groups. A corrected p value
of ⬍ 0.05 was required to reach significance. The reported n refers to the
sample size of each group within an experiment.
At least 3 PSC amplitudes were averaged for each autaptic neuron. For
each recording day, PSC amplitudes from experimental treatments were
normalized to the average amplitude in the control-treated sibling culture. For dual-component autaptic EPSCs, peak EPSC amplitude estimated the AMPA receptor component while the average current 80 –100
ms following the peak estimated the NMDA receptor component (Hestrin et al., 1990). Miniature EPSCs were elicited by perfusion of 100 mM
sucrose and analyzed using Mini Analysis software with manual confirmation. The first 57 miniature EPSC interevent interval and amplitude
values were used for Kolmogorov–Smirnov tests while values for all miniature EPSCs from a given neuron were averaged for Mann–Whitney U
tests.
At least 10 fields per culture dish were used to calculate the percentage
of live (calcein-positive) islands. For the percentage of FM1-43-positive
vGluT-1 synapses, regions of interest were manually drawn around 10
vGluT-1 puncta per field for 5 fields per culture dish. As previously
described (Crawford et al., 2011), FM1-43 images were thresholded before analyzing vGluT-1-defined regions, and synapses were considered
active if at least 10 pixels reached threshold. Similarly, 10 vGluT-1defined regions were manually drawn per field before analyzing synapsin
and phospho-synapsin images. The number and intensity of vGluT-1positive synapses in autaptic neurons was quantified via automatic detection in thresholded images using MetaMorph 7 software. Most
immunostaining experiments used glutamatergic autaptic neurons,
identified by vGluT-1 immunoreactivity. Glutamatergic neurons on
multicell islands were analyzed for nuclear phospho-CREB experiments,
however, and antibody incompatibility precluded double labeling in
phospho-dynamin 1 experiments. For display in figures, all images
within a panel were pseudocolored and adjusted for brightness and contrast equivalently.
Materials. Rp-cAMPS and 2-chloro-N 6-cyclopentyladenosine (CCPA)
were obtained from Tocris Bioscience, kainic acid was purchased from BioVectra, calcein-AM was purchased from AnaSpec, human recombinant
thrombospondin 1 (TSP1) was obtained from Hematologic Technologies, and tumor necrosis factor ␣ (TNF␣) was obtained from EMD Millipore. All other materials were obtained from Sigma-Aldrich unless
otherwise specified.

Results
Failure to mute in glutamatergic neurons from
astrocyte-poor cultures
We manipulated glial signaling in rat hippocampal cultures by
growing neurons on fixed or live astrocyte beds (Fig. 1 A). This
strategy, similar to prior studies using fixation to kill one cell type
before coculturing with other cell types (Amur-Umarjee et al.,
1993; Solà et al., 2002; Alexanian, 2005), permitted identical culture conditions for astrocyte-rich and astrocyte-poor cultures
except for the number of viable astrocytes. It also allowed control
neurons the full benefit of local and global astrocytic cues, unlike
preparations where control neurons only receive soluble astrocytic signals (Kaech and Banker, 2006). Electrophysiological
measures of input resistance (astrocyte-rich: 189.3 ⫾ 39.3 M⍀;
astrocyte-poor: 212.4 ⫾ 76.3 M⍀; n ⫽ 11–12 neurons; p ⫽ 0.77,
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Student’s unpaired t test), cell capacitance (astrocyte-rich: 73.3 ⫾
7.3 pF; astrocyte-poor: 94.0 ⫾ 10.3 pF; n ⫽ 14 –16 neurons; p ⫽
0.11, Student’s unpaired t test), and resting membrane potential
(astrocyte-rich: ⫺58.8 ⫾ 1.7 mV; astrocyte-poor: ⫺61.9 ⫾ 2.6 mV;
n ⫽ 10 neurons; p ⫽ 0.32, Student’s unpaired t test) were similar in
glutamatergic neurons from astrocyte-rich and astrocyte-poor cultures, suggesting no differences in membrane surface area or expression of background leak channels. We also detected no qualitative
differences in morphological complexity between neurons grown in
these two culture conditions, so gross differences in neuronal development were not apparent.
To test whether astrocytes are important for muting of
glutamatergic synapses, we attempted to induce muting in
neurons from astrocyte-rich and astrocyte-poor cultures. EPSCs from DIV 10 –14 autaptic neurons in astrocyte-rich microcultures were persistently depressed with as little as 60 min
depolarization, as assessed up to 1 h following the removal of
depolarization (Fig. 1 B, C), while 30 min of depolarization
yielded insignificant muting ( p ⫽ 0.45). We have shown previously that this depolarization-induced depression is selective for glutamate synapses and arises from muting in the
absence of synapse loss or postsynaptic receptor changes
(Moulder et al., 2004, 2006). By contrast, neurons in
astrocyte-poor cultures exhibited no EPSC depression with up
to 4 h depolarization, which produced strong muting in
astrocyte-rich cultures (Fig. 1 B, C). Neurons from astrocytepoor cultures perfused for 10 s with 30 mM KCl in recording
saline depolarized to the same steady-state membrane potential as those from astrocyte-rich cultures (astrocyte-rich:
⫺17.3 ⫾ 2.5 mV; astrocyte-poor: ⫺17.4 ⫾ 2.0 mV; n ⫽ 10
neurons; p ⫽ 0.97, Student’s unpaired t test), suggesting that
the induction protocol depolarizes neurons from both conditions similarly. Muting, therefore, is impaired in astrocytepoor cultures.
To evaluate an alternative method of muting induction, we
incubated cells in Gi/o-coupled receptor agonists CCPA (an A1
adenosine receptor agonist) and baclofen (a GABAB receptor agonist) or in PKA antagonist Rp-cAMPS. Both treatments induce
presynaptic muting (Moulder et al., 2008; Crawford et al., 2011).
These agents depressed EPSCs in astrocyte-rich cultures, as expected, but significantly increased EPSC amplitudes in astrocytepoor cultures (Fig. 1C). This unexpected reversal of EPSC
depression indicated an abnormality in muting induction. Meanwhile, canonical acute presynaptic depression, mediated by G␤␥
subunit signaling (Brown and Sihra, 2008), did not differ in
astrocyte-poor cultures; autaptic EPSCs were acutely depressed
by both the GABAB receptor agonist baclofen (astrocyte-rich:
74.9 ⫾ 4.5%; astrocyte-poor: 63.9 ⫾ 5.5%; n ⫽ 11; p ⫽ 0.14,
Student’s paired t test; Fig. 1 D) and the A1 adenosine receptor
agonist CCPA (astrocyte-rich: 61.0 ⫾ 6.2%; astrocyte-poor:
46.6 ⫾ 4.6%; n ⫽ 11; p ⫽ 0.08, Student’s paired t test; Fig. 1 E)
4

Figure 2. Astrocyte deprivation does not impair basal presynaptic function. A, EPSCs from
autaptic neurons in astrocyte-poor cultures from islands with residual live astrocytes (calceinpositive) or no live astrocytes (calcein-negative). B, Images of 10 M FM1-43FX labeling of
presynaptic terminals (green) after 2 min 45 mM KCl and subsequent vGluT-1 immunostaining

(magenta) in autaptic neurons from astrocyte-rich and astrocyte-poor cultures (30 min,
⫺20°C, 70% EtOH-fixed astrocytes). Scale bar, 5 m. C, vGluT-1 (magenta) and MAP2 (cyan)
immunostaining in autaptic neurons showing similar density and intensity of presynaptic terminals. Scale bar, 20 m. Summary results for A–C are given in the Results. D, Calcium concentration–response curves of autaptic EPSC amplitudes from astrocyte-rich or astrocyte-poor
cultures normalized for each neuron to values obtained in 5 mM external calcium (n ⫽ 21–22).
Data from astrocyte-rich cultures were fitted to the Hill equation (EC50 value: 1.8 mM; Hill
coefficient: 2.7). Inset, Non-normalized values from the same dataset demonstrating basal
depression of EPSCs in astrocyte-poor cultures at higher calcium concentrations. *p ⬍ 0.05,
Student’s unpaired t test, Bonferroni corrected.
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similarly in astrocyte-rich and astrocyte-poor cultures. The muting deficit in astrocyte-deprived neurons, therefore, is likely
downstream of depolarization and G␣i/o subunit-mediated
cAMP signaling.
Normal basal presynaptic function in astrocyte-poor cultures
The basal EPSC amplitude was smaller in astrocyte-deprived cultures than in astrocyte-rich cultures (astrocyte-rich: ⫺18.3 ⫾ 5.7
nA; astrocyte-poor: ⫺5.0 ⫾ 1.4 nA; n ⫽ 15–16; p ⫽ 0.037, Student’s unpaired t test); however, IPSCs were similar (astrocyterich: ⫺7.6 ⫾ 2.5 nA; astrocyte-poor: ⫺8.7 ⫾ 1.9 nA; n ⫽ 14
neurons; p ⫽ 0.74, Student’s unpaired t test), suggesting that the
basal deficit in amplitude in astrocyte-poor cultures localized
specifically to glutamatergic synapses. The decreased EPSC amplitude was not explained by differences in local astrocytic signaling because neurons in astrocyte-deprived cultures on islands
with some of the few contaminating live astrocytes did not have
larger EPSCs than neurons associated with nonviable islands, as
assessed by a vital stain (viable islands: ⫺2.0 ⫾ 0.5 nA; nonviable
islands: ⫺4.8 ⫾ 1.5 nA; n ⫽ 13–16 neurons; p ⫽ 0.13, Student’s
unpaired t test; Fig. 2A). A global deficit in astrocyte-poor cultures, therefore, likely explains the basal EPSC depression.
Decreased functionally active presynaptic terminals did not
explain the basal EPSC depression or the deficient stimulusinduced muting in astrocyte-poor cultures. The percentage of
basally active terminals, as measured via stimulus-induced FM143FX dye labeling of vesicles at vGluT-1-immunoreactive synapses, was similar in astrocyte-rich and astrocyte-poor cultures
(astrocyte-rich: 48.0 ⫾ 4.1%; astrocyte-poor: 54.5 ⫾ 7.0%; n ⫽ 8
dishes; p ⫽ 0.44, Student’s unpaired t test; Fig. 2 B). Furthermore, neither the number (astrocyte-rich: 188.3 ⫾ 35.7 puncta;
astrocyte-poor: 174.1 ⫾ 21.8 puncta; n ⫽ 35 neurons; p ⫽ 0.74,
Student’s unpaired t test) nor the intensity [astrocyte-rich: 410 ⫾
58 ⫻ 1000 arbitrary units (AU); astrocyte-poor: 388 ⫾ 65 ⫻ 1000
AU; n ⫽ 35 neurons; p ⫽ 0.80, Student’s unpaired t test] of
vGluT-1 puncta per cell differed, suggesting normal synapse
and vesicle numbers (Fig. 2C). Paired-pulse EPSC depression
was also normal, suggesting similar vesicle release probability
(astrocyte-rich: 5.1 ⫾ 9.2%; astrocyte-poor: 18.2 ⫾ 8.6%; n ⫽
15–16; p ⫽ 0.3, Student’s unpaired t test), and normalized
calcium concentration–response relationships were similar in
astrocyte-rich and astrocyte-poor cultures (Fig. 2 D). EPSCs remained depressed in astrocyte-poor cultures at the highest calcium concentration (5 mM; Fig. 2 D), suggesting that deficits did
not arise from altered coupling of calcium influx to vesicle fusion.
No deficits in presynaptic function, therefore, were detected with
reduced astrocytic signaling.
Basal postsynaptic deficits in astrocyte-poor cultures
A postsynaptic deficit, rather, appeared to explain the basal EPSC
depression in astrocyte-poor cultures. AMPA receptor and
NMDA receptor components of EPSCs were reduced in parallel
(astrocyte-rich: 0.34 ⫾ 0.06 NMDA/AMPA receptor EPSC ratio;
astrocyte-poor: 0.47 ⫾ 0.12 NMDA/AMPA receptor EPSC ratio;
n ⫽ 14 –15 neurons; p ⫽ 0.34, Student’s unpaired t test; Fig. 3A),
and this parallel depression was associated with decreased responsiveness to exogenously applied AMPA receptor agonist
kainic acid (20 M; astrocyte-rich: ⫺12.2 ⫾ 1.7 pA/pF; astrocytepoor: ⫺5.9 ⫾ 1.0 pA/pF; n ⫽ 14 –15 neurons; p ⫽ 0.004, Student’s unpaired t test; Fig. 3B) and NMDA receptor agonist
NMDA (10 M; astrocyte-rich: ⫺12.9 ⫾ 1.7 pA/pF; astrocytepoor: ⫺7.3 ⫾ 0.8 pA/pF; n ⫽ 14 –15 neurons; p ⫽ 0.003, Student’s unpaired t test; Fig. 3B). The preserved ratio of NMDA to

Figure 3. Glutamate receptor levels are decreased in astrocyte-poor cultures. A, Representative dual-component (NMDA and AMPA receptor-mediated) EPSCs elicited in autaptic neurons from astrocyte-rich or astrocyte-poor cultures. Note the change in vertical scale bar. B, Top,
Currents from autaptic neurons in astrocyte-rich or astrocyte-poor cultures in response to acute
kainic acid (KA) perfusion, a nondesensitizing AMPA receptor agonist. Bottom, Currents from
autaptic neurons in astrocyte-rich or astrocyte-poor cultures in response to acute NMDA perfusion to selectively activate NMDA receptors. C, Top, representative miniature EPSCs from
astrocyte-rich or astrocyte-poor cultures elicited by acute perfusion of 100 mM sucrose. Bottom,
Cumulative probability plots of amplitude ( p ⬍ 0.001 with D ⫽ 0.2175) and interevent interval
( p ⬍ 0.001 with D ⫽ 0.3860) of miniature EPSCs (n ⫽ 10; Kolmogorov–Smirnov test). Additional summary data for A–C are given in the Results.

AMPA receptor responses to exogenous agonists (astrocyte-rich:
1.26 ⫾ 0.36; astrocyte-poor: 1.93 ⫾ 0.41; n ⫽ 14 –15 neurons; p ⫽
0.16, Student’s unpaired t test; Fig. 3B) further implies that
NMDA receptors and AMPA receptors were reduced in parallel
and that both synaptic and extrasynaptic receptor levels were
decreased. Additionally, miniature EPSC (mEPSC) amplitude
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Student’s unpaired t test). Together, these
results suggest that neurons in astrocytepoor cultures have fewer functional glutamate receptors.
To ask whether the decreased basal EPSC
amplitude contributed to the muting deficit
in astrocyte-poor cultures, we attempted to
induce muting in young (DIV 7– 8),
astrocyte-rich cultures. Despite smaller
basal EPSC amplitudes similar to those
found in DIV 10 –14 astrocyte-poor cultures (⫺3.75 ⫾ 0.95 nA; n ⫽ 17), these
younger neurons in astrocyte-rich cultures
expressed muting in response to a 4 h depolarization challenge (Fig. 4A,E). Conversely, older (DIV 21), astrocyte-poor
cultures with larger basal EPSC amplitudes
(10.27 ⫾ 4.02 nA; n ⫽ 12) did not exhibit
muting (Fig. 4E). Together with prior published studies suggesting that postsynaptic
glutamate receptor function is not required
for muting induction (Moulder et al., 2004,
2006), these data suggest that the postsynaptic changes caused by astrocyte deficiency
did not explain the muting deficits. Because
glial modulation of glutamate receptor levels and function has been studied previously (Beattie et al., 2002; Stellwagen and
Malenka, 2006; Perea et al., 2009; Sullivan et
al., 2011), we did not further characterize
the mechanisms responsible for this postsynaptic deficit in astrocyte-poor cultures.
Thrombospondin as an astrocytederived permissive factor for muting
Astrocytes could directly instruct muting during depolarization (e.g., through
gliotransmission), or they could permit
development of muting competence
(e.g., through global cues). In support of
the latter, conditioned medium from
Figure 4. Soluble, astrocyte-derived thrombospondin rescues presynaptic muting competence. A–D, Representative DIV 7–12 mature, live-astrocyte cultures added to
autaptic EPSCs after 4 h control treatment (30 mM NaCl) or depolarization (30 mM KCl). Cultures were astrocyte-rich and challenged astrocyte-poor cultures at DIV 7 resat DIV 7 without additional treatments (A), astrocyte-poor, treated with astrocyte-conditioned medium (CM) at DIV 7, and chal- cued muting, even when conditioned
lenged at DIV 10 –12 (B), astrocyte-poor and challenged at DIV 10 –12 in CM (C), or astrocyte-poor, treated with 5 g/ml human
medium was replaced with fresh methrombospondin 1 (TSP) at DIV 7, and challenged at DIV 10 –12 (D). E, Summary of EPSC amplitudes after 4 h 30 mM KCl or 50 M
dium during the depolarization challenge
Rp-cAMPS (Rp) with indicated pretreatments and/or cotreatments (n ⫽ 12–20 neurons; *p ⬍ 0.05 vs treatment controls,
Student’s unpaired t test). EPSCs were normalized as in Figure 1C. ⫹, Astrocyte-rich cultures; ⫺, astrocyte-poor cultures; GBP, 32 (Fig. 4 B, E). Conditioned medium was ineffective if applied only during the muting
M gabapentin; TNF␣, 1 ng/ml tumor necrosis factor ␣; FM, fresh, non-conditioned medium.
induction protocol (Fig. 4C,E). Thus, glial
factors are not released instructively durwas reduced (astrocyte-rich: 19.7 ⫾ 2.1 pA; astrocyte-poor:
ing muting induction and are, instead, released permissively dur13.4 ⫾ 1.1 pA; n ⫽ 10 neurons; p ⬍ 0.01, Mann–Whitney U test;
ing synapse development. Because older (DIV 21), astrocyteFig. 3C), further suggesting that postsynaptic receptor levels were
poor cultures failed to express muting (Fig. 4 E), it is unlikely that
decreased in astrocyte-poor cultures. Frequency of mEPSCs also
muting
competence was delayed in the absence of astrocytes.
trended toward reduction (astrocyte-rich: 0.39 ⫾ 0.22 s interRather, it appears that astrocytes provide a fundamental developevent interval; astrocyte-poor: 1.03 ⫾ 0.28 s interevent interval;
mental cue that permits muting competence.
n ⫽ 10 neurons; p ⬎ 0.05, Mann–Whitney U test; Fig. 3C), but it
We hypothesized that astrocytes release a permissive subwas unclear whether this resulted from an undetected presynapstance
for muting development rather than remove a nonpermistic change or whether the smallest mEPSCs fell below the detecsive factor. Astrocyte-derived TSPs foster presynaptic maturation
tion threshold. Immunoreactivity for surface levels of the AMPA
via binding to the neuronal ␣2␦-1 subunit of voltage-gated calreceptor subunit GluA2 was also reduced, with fewer vGluT-1cium channels or to neuroligin 1 (Eroglu et al., 2009; Xu et al.,
defined synapses colocalizing with GluA2 (astrocyte-rich: 66.7 ⫾
2010). Synaptogenic effects of TSPs are mediated redundantly by
2.3%; astrocyte-poor: 59.0 ⫾ 2.9%; n ⫽ 46 – 48 fields; p ⫽ 0.039,
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the 5 TSP isoforms (Eroglu et al., 2009),
and TSP1 is expressed strongly in hippocampus (Adams and Tucker, 2000).
We, therefore, tested effects of adding human TSP1 (5 g/ml) to astrocyte-poor
cultures. Incubation in human TSP1
starting at DIV 7 rescued presynaptic
muting competence in astrocyte-poor
cultures (Fig. 4 D, E). In contrast, TNF␣ (1
ng/ml), an astrocyte-derived factor involved in postsynaptic plasticity (Beattie
et al., 2002; Stellwagen et al., 2005; Stellwagen and Malenka, 2006; Steinmetz and
Turrigiano, 2010), did not rescue muting
in astrocyte-poor cultures (Fig. 4 E).
These data suggest that TSP1 is capable of
promoting muting competence but do
not clarify whether TSPs are the endogenous astrocytic factors responsible.
Prevention of muting by gabapentin, a
blocker of thrombospondin-␣2␦-1
binding
To test for the receptor through which
TSP1 promotes muting, we blocked TSP
binding to the candidate receptor ␣2␦-1
using gabapentin, a clinically used drug
for the treatment of human neuropathic
pain and epilepsy. Gabapentin interferes with TSP binding to ␣2␦-1 and
prevents TSP’s synaptogenic effects in
retinal ganglion neurons (Gee et al.,
1996; Eroglu et al., 2009). In astrocytepoor cultures, gabapentin (32 M) abolished conditioned medium rescue of
depolarization-induced muting (Fig. 4E),
suggesting that TSPs are likely the astrocytederived regulators of muting competence.
We also evaluated the effect of gabapentin in
live-astrocyte cultures, where ongoing production of astrocytic TSPs was an additional
consideration. In these cultures, a single
treatment with gabapentin at DIV 7 was ineffective in preventing silencing, as assessed
at DIV 10 –12 (control: 100.0 ⫾ 22.6%; depolarized 29.8 ⫾ 7.9%; n ⫽ 12 neurons;
p⫽0.008, Student’s unpaired t test; Fig. 5A);
however, 3–5 d maintenance of gabapentin
by partial medium exchange in astrocyterich cultures eliminated depolarizationinduced muting (control: 100.0 ⫾ 20.0%; Figure 5. Gabapentinpreventsthedevelopmentofmutingcompetence.A,RepresentativeDIV10 –12autapticEPSCsafter4hcontrol
depolarized 103.6 ⫾ 19.8%; n ⫽ 12 neu- treatment (30 mM NaCl) or depolarized (30 mM KCl). Astrocyte-rich cultures were treated with 32 M gabapentin at DIV 7 (1⫻ GBP). B,
Representative DIV 10 –12 autaptic EPSCs after 4 h control or depolarized. Astrocyte-rich cultures were treated with 32 M gabapentin at
rons; p ⫽ 0.90, Student’s unpaired t test; Fig. DIV7followedbyhalf-mediaswitchesoffresh32 M gabapentininastrocyte-conditionedmediumeveryday(3–5⫻GBP).Summarydata
5B). These results suggest that gabapentin for A and B are given in the Results. C, Spontaneous activity in DIV 11–13 mass cultures after 4 h control treatment (30 mM NaCl) or
also blocks endogenously released factors depolarized (30 mM KCl). Cultures were treated at DIV 7 with or without 32 M gabapentin followed by daily half media switches with
important for muting when the ongoing astrocyte-conditionedmedium(CM)orCMplus32 M gabapentin(3–5⫻GBP).EPSCsandIPSCsweremeasuredsimultaneouslyat⫺35
production of the factors is taken into mV.D,Summaryoftotalspontaneoussynapticactivity(EPSC⫹IPSCpoints)inDIV11–13masscultures,normalizedtocontrol(CM,NaCl)
for each recording day (n ⫽ 23 neurons; *p ⬍ 0.05, Bonferroni corrected).
account.
To test whether using gabapentin to block
endogenous TSP could have implications for neural network function,
ing induction (Fig. 5C,D), consistent with an adaptive role for muting
we measured spontaneous network activity after muting induction in
(Hogins et al., 2011; Crawford and Mennerick, 2012). In
control and gabapentin-treated cultures. These astrocyte-rich, convengabapentin-treated cultures, however, a nonsignificant increase in
tional mass cultures exhibited decreased spontaneous activity after mutnetwork activity was observed (p ⫽ 0.16, Bonferroni corrected), but
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PKA-dependent phosphorylation
normalization by thrombospondin in
astrocyte-poor cultures
Although the signaling pathways downstream of ␣2␦-1 are unclear, we hypothesized that PKA signaling, which regulates
muting (Moulder et al., 2008), is altered in
astrocyte-deprived neurons. This hypothesis was based in part on the observations
that both Gi/o-coupled receptor agonistinduced muting and Rp-cAMPS-induced
muting were dysfunctional (Fig. 1C). To test
whether PKA activity was normal in
astrocyte-poor cultures, we measured phosphorylation levels of PKA substrates in neurons. We found that phosphorylation levels
of the presynaptic protein synapsin at its
PKA phosphorylation site were increased in
vGluT-1-defined synapses in astrocytepoor cultures (Fig. 6A,B). Immunoreactivity of total synapsin levels was unchanged,
however (astrocyte-rich: 28.6 ⫾ 1.8 ⫻ 1000
AU; astrocyte-poor: 30.2 ⫾ 1.7 ⫻ 1000 AU;
n ⫽ 35 neurons; p ⫽ 0.51, Student’s unpaired t test; Fig. 6C). Phosphorylation of
CREB, another PKA substrate, was also abnormally high in neuronal nuclei from
GABA-negative neurons in astrocytedeprived cultures, as measured via immunoreactivity (astrocyte-rich: 3.8 ⫾ 0.3 ⫻
1000 AU; astrocyte-poor 15.5 ⫾ 1.2 ⫻ 1000
AU; n ⫽ 60 – 89 neurons; p ⫽ 3.7 ⫻ 10 ⫺13,
Student’s unpaired t test; Fig. 7A). In contrast, phosphorylation of dynamin 1, a PKC
substrate, was unchanged in astrocyte-poor
cultures (Fig. 7B), suggesting that hyperphosphorylation was restricted to PKA
phosphorylation sites. TSP1 incubation in
astrocyte-poor cultures reversed abnormal
presynaptic phospho-synapsin (Fig. 6A,B),
so TSP appears to restore normal PKA targeting and/or activity. Furthermore, TSP1
incubation reinstated normal Rp-cAMPSinduced persistent EPSC depression in
astrocyte-poor cultures (Fig. 4E). Together,
these results suggest that TSP promotes
muting competence via normalization of
signaling downstream of cAMP pathways.

Discussion
Here we have demonstrated that astrocytes serve as permissive partners in the
development of a form of persistent synaptic depression: presynaptic muting. In
glutamatergic neurons from astrocytepoor cultures, basal presynaptic function
remained intact, suggesting that astrocytes modulate presynaptic plasticity
competence differently than they regulate
other types of presynaptic development.
Astrocytic signaling was permissive, but not acutely instructive,
for muting induction. Astrocyte-derived TSPs promoted the development of muting ability, as induced with varied stimuli,

Figure 6. PKA-dependent hyperphosphorylation of synapsin is normalized by thrombospondin. A, Phospho-synapsin (PKA
phosphorylation site) immunostaining in DIV 10 –12 autaptic neurons from astrocyte-rich or astrocyte-poor cultures with or
without 5 g/ml TSP treatment at DIV 7. Red circles are representative regions of interest defined by vGluT-1 immunoreactivity
(data not shown). Scale bar, 5 m. B, Summary of background-subtracted phospho-synapsin at vGluT-1-positive synapses in DIV
10 –12 autaptic neurons (n ⫽ 35 neurons; *p ⬍ 0.05, Bonferroni corrected). C, Synapsin immunostaining at vGluT-1-defined
synapses (red circles are representative) in autaptic neurons from astrocyte-rich or astrocyte-poor cultures. Summary immunoreactivity values are given in the Results. Scale bar, 5 m.

network activity did not change after the muting induction protocol
(Fig. 5C,D), suggesting that muting was not induced. Together, these
results argue that TSP binding to ␣2␦-1 fosters development of presynaptic muting competence.
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likely through ␣2␦-1 calcium channel
subunits. Although the signaling pathways immediately downstream of ␣2␦-1
remain to be clarified, PKA appears to
be an important downstream effector.
PKA-dependent phosphorylation and
synaptic behavior were abnormal in
astrocyte-poor cultures but restored by
TSP1 treatment, providing a potential
mechanism by which TSP modulates
muting competence.
TSPs were originally discovered in human blood platelets (Baenziger et al.,
1971). In the brain, at least 4 TSPs are expressed in various regions and cell types
(Iruela-Arispe et al., 1993; Adams and
Tucker, 2000). TSPs are released from astrocytes and promote synaptogenesis
(Asch et al., 1986; Christopherson et al.,
2005; Xu et al., 2010), but because TSPinduced glutamate synapses in retinal
ganglion cells are postsynaptically silent
(Christopherson et al., 2005; Eroglu et al.,
2009), TSPs may be involved mainly in
presynaptic rather than postsynaptic differentiation. This is especially interesting
because postsynaptic TSP actions produce Figure 7. A PKA target, but not a non-PKA target, is hyperphosphorylated in astrocyte-poor cultures. A, MAP2, GABA, and
these presynaptic effects (Eroglu et al., phospho-CREB (PKA phosphorylation site) immunoreactivity in neurons on multicell islands from astrocyte-rich or astrocyte-poor
2009; Xu et al., 2010). TSP increases the cultures. Summary pCREB immunoreactivity values are given in the Results. Scale bar, 20 m. B, Left, Phospho-dynamin 1 (PKC
phosphorylation site) immunoreactivity in autaptic neurons from astrocyte-rich and astrocyte-poor cultures. Scale bar, 20 m.
total number of synapses in retinal gan- Right, Quantification of background-subtracted phospho-dynamin 1 intensity from a single primary and two secondary dendrites
glion cells (Christopherson et al., 2005; averaged per neuron. As a positive control, we treated for 30 min with phorbol ester (1 M PDBu), which increased PKC-dependent
Eroglu et al., 2009) but accelerates synap- phosphorylation of dynamin 1 (n ⫽ 30 neurons; *p ⬍ 0.05, Bonferroni corrected).
togenesis without altering total synapse
number in hippocampal neurons (Xu et
inal ganglion neurons (Eroglu et al., 2009), and we found that
al., 2010). Glial cells exhibit regional differences in synaptogenic
gabapentin prevented the development of muting competence in
effects (Steinmetz et al., 2006). This regional difference could
hippocampal neurons, implicating TSP binding to ␣2␦-1 in this
explain why astrocyte deprivation failed to change total presyneffect. Interestingly, calcium channel function was not detectably
aptic terminal number in our study of hippocampal neurons and
altered in astrocyte-poor cultures in our study, as evidenced by
why TSP’s effects on hippocampal synaptic plasticity have been
the lack of change in vesicle release probability and calcium conpreviously overlooked. Although muting is found in a variety of
centration–response curves. Consistent with prior literature
preparations (Crawford and Mennerick, 2012), future work
(Eroglu et al., 2009; Hoppa et al., 2012), this suggests that thromshould clarify whether TSP’s effects on muting are brain regionbospondin’s and gabapentin’s effects do not arise via alterations
specific or whether they constitute a widespread mechanism. Bein calcium channel function. These results emphasize that future
cause TSP expression increases after injury and is important for
work needs to clarify the mechanism by which ␣2␦-1 alters mutbehavioral recovery after stroke, TSP may be important generally
ing competence.
for adaptive neuronal responses (Lin et al., 2003; Liauw et al.,
Muting incompetence caused by gabapentin could also have
2008; but see Kim et al., 2012). Presynaptic muting, which reclinical
implications. Previous studies have demonstrated a wide
duced network activity during an excitatory insult during this
variety
of
effects of gabapentin on synaptic and behavioral plasstudy and protected neurons against hypoxia in a prior study
ticity
including
no effect (Cilio et al., 2001; Heidegger et al.,
(Hogins et al., 2011), could be one such TSP-mediated synaptic
2010),
reduced
plasticity
(Blake et al., 2007; Eroglu et al., 2009;
mechanism contributing to adaptive neural responses during
Kurokawa et al., 2011), and enhanced learning (Buccafusco et al.,
brain insults.
2010). In our study, gabapentin blocked adaptive network
TSP promoted muting competence through its interaction
changes in response to a stimulus known to selectively induce
with the ␣2␦-1 calcium channel subunit. This subunit serves as
muting. Although we saw a nonsignificant increase in total netthe TSP receptor for synaptogenesis in retinal ganglion cells (Erowork activity after gabapentin treatment, this likely does not exglu et al., 2009) and as the receptor for the antinociceptive and
plain the lack of muting since muting is promoted by increased
anticonvulsant drug gabapentin (Gee et al., 1996). Gabapentin’s
network activity (Moulder et al., 2004, 2006). The prevention of
therapeutic effects may arise from alterations in calcium channel
adaptive muting appears counterintuitive for gabapentin because
organization (Arikkath and Campbell, 2003; Field et al., 2006;
it is a therapeutic agent. Our study and a previous study (Eroglu
Bauer et al., 2009; Bauer et al., 2010; Hoppa et al., 2012), among
et al., 2009) suggest that synaptogenic periods might be particuother neuronal changes (Freiman et al., 2001; Gu and Huang,
larly vulnerable to unintended effects of gabapentin. Therapeutic
2001; Stefani et al., 2001; Surges et al., 2003). Gabapentin binding
to ␣2␦-1 antagonizes TSP-induced synaptic development in retbenefits have been hypothesized to arise from gabapentin’s block
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of synaptogenesis (Eroglu et al., 2009; Lo et al., 2011) and reduction of calcium channel function or trafficking (Rogawski and
Löscher, 2004). Because synapse formation was not hindered and
calcium channels did not differ functionally in astrocyte-poor
cultures compared with astrocyte-rich cultures, these effects of
gabapentin likely did not contribute to muting prevention. Gabapentin’s effects on muting may instead work through a different molecular pathway and become detrimental to the neural
network only after a secondary excitatory insult. Future work
should clarify the contexts under which multiple effects of gabapentin alter neuronal function.
Our work implicates PKA signaling in TSP’s promotion of
muting competence. Gi/o-linked receptor agonists and PKA inhibitors, which normally produce muting (Moulder et al., 2008;
Crawford et al., 2011), persistently potentiated EPSCs in
astrocyte-poor cultures. Additionally, PKA substrates in the presynaptic terminal and the nucleus were hyperphosphorylated in
astrocyte-deprived cultures, indicating an abnormal increase in
PKA site phosphorylation or a decrease in dephosphorylation.
This surprising synaptic facilitation may suggest that multiple
cAMP-dependent pathways regulate synaptic transmission. It is
possible that PKA inhibition normally suppresses transmission
by dominating or masking other potentiating effects that are then
revealed in the context of astrocyte deprivation and hyperphosphorylated PKA substrates. Astrocyte-released TSPs, therefore,
may restrain PKA activity, or phosphorylation levels of its substrates, during synaptic development so that PKA inhibition can
produce a meaningful decrease in synaptic function upon exposure to the depolarization challenge. Other explanatory models
are possible, and future work may distinguish them.
In addition to effects on synaptic plasticity, we also observed
effects of astrocyte deprivation on basal postsynaptic function.
Neuronal responses to AMPA and NMDA receptor agonists were
depressed in parallel, supporting prior work suggesting that astrocytes are important for postsynaptic development (Beattie et
al., 2002; Stellwagen and Malenka, 2006; Perea et al., 2009; Sullivan et al., 2011). Because neurons near live astrocytes in
astrocyte-poor cultures produced EPSCs that were statistically
indistinguishable from those on dead astrocytes, depressed basal
EPSCs likely resulted from a deficit in global astrocytic signaling
rather than a deficit in local signaling. It is unlikely that the basal
EPSC deficit caused the deficit in muting because the failure to
mute persisted in older, astrocyte-deprived cultures with larger
basal EPSCs. Furthermore, muting persists in the presence of
complete blockade of AMPA and NMDA receptor function
(Moulder et al., 2004, 2006). Our results do not exclude a role for
TSP and ␣2␦-1 in basal postsynaptic development, however, but
TSP’s role in muting appears independent of postsynaptic receptor function.
In summary, astrocyte-derived TSPs permit presynaptic
muting at hippocampal glutamate terminals. TSPs likely act
through ␣2␦-1 binding to normalize PKA signaling in developing synapses. These results reveal a novel mechanism by
which glial-neuronal communication controls adaptive synaptic malleability.
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